Just weeks after disclosing it had raised $13.3 million in venture capital, mobile clinical software developer PatientSafe Solutions has upped the total to $20 million to close its Series C financing round, the company said Monday.
The Merck Global Health Innovation Fund, a unit of pharmaceutical giant Merck & Co., led the round, which also included Camden Partners, TPG Capital and Psilos...
